Proteasome Inhibitors Evoke Latent Tumor Suppression Programs in Pro-B MLL Leukemias Through MLL-AF4

Chromosomal translocations disrupting MLL generate MLL-fusion proteins that induce aggressive leukemias. Unexpectedly, MLL-fusion proteins are rarely observed at high levels, suggesting excessive MLL-fusions may be incompatible with a malignant phenotype. Here, we used clinical proteasome inhibitors...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liu, Han, Westergard, Todd D., Cashen, Amanda, Piwnica-Worms, David R., Kunkle, Lori, Vij, Ravi, Pham, Can G., DiPersio, John, Cheng, Emily H., Hsieh, James J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4097146/
https://ncbi.nlm.nih.gov/pubmed/24735925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2014.03.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados